tradingkey.logo
tradingkey.logo
Search

Balchem Corp

BCPC
Add to Watchlist
159.020USD
-2.070-1.28%
Close 05/15, 16:00ETQuotes delayed by 15 min
5.11BMarket Cap
32.33P/E TTM

Balchem Corp

159.020
-2.070-1.28%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Balchem Corp

Currency: USD Updated: 2026-05-15

Key Insights

Balchem Corp's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 24 out of 67 in the Chemicals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 200.75.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Balchem Corp's Score

Industry at a Glance

Industry Ranking
24 / 67
Overall Ranking
141 / 4482
Industry
Chemicals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Neutral

Balchem Corp Highlights

StrengthsRisks
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 1.04B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 22.16%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 22.16%.
Undervalued
The company’s latest PB is 3.98, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 28.38M shares, decreasing 6.62% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 203.00 shares of this stock.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
200.750
Target Price
+24.62%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Balchem Corp is 9.24, ranking 2 out of 67 in the Chemicals industry. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 270.71M, representing a year-over-year increase of 8.06%, while its net profit experienced a year-over-year increase of 8.72%.

Score

Industry at a Glance

Previous score
9.24
Change
0

Financials

9.50

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

8.80

Operational Efficiency

8.97

Growth Potential

9.36

Shareholder Returns

9.60

Balchem Corp's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Balchem Corp is 3.54, ranking 66 out of 67 in the Chemicals industry. Its current P/E ratio is 32.33, which is 54.86% below the recent high of 50.07 and 5.88% above the recent low of 30.43.

Score

Industry at a Glance

Previous score
3.54
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 24/67
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

The current earnings forecast score of Balchem Corp is 7.33, ranking 36 out of 67 in the Chemicals industry. The average price target is 191.00, with a high of 220.00 and a low of 162.00.

Score

Industry at a Glance

Previous score
7.33
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 3 analysts
Buy
Current Rating
200.750
Target Price
+24.62%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

64
Total
4
Median
6
Average
Company name
Ratings
Analysts
Balchem Corp
BCPC
3
Apple Inc
AAPL
49
Ge Vernova Inc
GEV
36
Tapestry Inc
TPR
24
Verisk Analytics Inc
VRSK
20
Avantor Inc
AVTR
20
1
2
3
...
13

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Balchem Corp is 6.68, ranking 42 out of 67 in the Chemicals industry. Currently, the stock price is trading between the resistance level at 172.73 and the support level at 151.28, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
6.84
Change
-0.16

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(3)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-1.255
Sell
RSI(14)
34.370
Neutral
STOCH(KDJ)(9,3,3)
31.911
Neutral
ATR(14)
4.517
High Vlolatility
CCI(14)
-58.729
Neutral
Williams %R
91.216
Oversold
TRIX(12,20)
-0.347
Sell
StochRSI(14)
43.863
Sell
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
159.832
Sell
MA10
160.424
Sell
MA20
166.590
Sell
MA50
168.831
Sell
MA100
168.678
Sell
MA200
161.666
Sell

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Balchem Corp is 7.00, ranking 28 out of 67 in the Chemicals industry. The latest institutional shareholding proportion is 88.34%, representing a quarter-over-quarter decrease of 4.74%. The largest institutional shareholder is Wasatch Global Investors, holding a total of 1.42M shares, representing 4.43% of shares outstanding, with 35.17% increase in holdings.

Score

Industry at a Glance

Previous score
7.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
4.42M
+1.69%
Wasatch Global Investors Inc
Star Investors
1.18M
+9.29%
Conestoga Capital Advisors, LLC
1.20M
-5.38%
State Street Investment Management (US)
1.21M
+0.77%
Geode Capital Management, L.L.C.
1.01M
+1.00%
Geneva Capital Management LLC
907.80K
-8.12%
Dimensional Fund Advisors, L.P.
597.95K
+3.26%
Congress Asset Management Company, LLP
378.75K
+1.77%
1
2

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Chemicals domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Balchem Corp is 9.54, ranking 4 out of 67 in the Chemicals industry. The company's beta value is 0.84. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. Balchem Corp’s latest ESG disclosure leads the Chemicals industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.

Score

Industry at a Glance

Previous score
9.54
Change
0
Beta vs S&P 500 index
0.84
VaR
+2.37%
240-Day Maximum Drawdown
+16.52%
240-Day Volatility
+25.95%

Return

Best Daily Return
60 days
+2.56%
120 days
+4.10%
5 years
+6.28%
Worst Daily Return
60 days
-6.76%
120 days
-6.76%
5 years
-6.95%
Sharpe Ratio
60 days
-1.82
120 days
+0.50
5 years
+0.30

Risk Assessment

Maximum Drawdown
240 days
+16.52%
3 years
+23.50%
5 years
+34.14%
Return-to-Drawdown Ratio
240 days
-0.24
3 years
+0.26
5 years
+0.13
Skewness
240 days
-0.11
3 years
+0.16
5 years
+0.05

Volatility

Realised Volatility
240 days
+25.95%
5 years
+27.21%
Standardised True Range
240 days
+2.30%
5 years
+2.17%
Downside Risk-Adjusted Return
120 days
+71.57%
240 days
+71.57%
Maximum Daily Upside Volatility
60 days
+15.06%
Maximum Daily Downside Volatility
60 days
+22.13%

Liquidity

Average Turnover Rate
60 days
+0.62%
120 days
+0.59%
5 years
--
Turnover Deviation
20 days
+33.91%
60 days
+25.42%
120 days
+20.05%

Peer Comparison

Chemicals
Balchem Corp
Balchem Corp
BCPC
7.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
CF Industries Holdings Inc
CF Industries Holdings Inc
CF
8.52 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ecovyst Inc
Ecovyst Inc
ECVT
8.51 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Koppers Holdings Inc
Koppers Holdings Inc
KOP
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Element Solutions Inc
Element Solutions Inc
ESI
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ashland Inc
Ashland Inc
ASH
8.10 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI